Article
Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP.
Cancer chemotherapy and pharmacology - 1 Feb 2010
Chae Yee Soo, Kim Jong Gwang, Sohn Sang Kyun, Moon Joon Ho, Kim Shi Nae, Lee Su Jeong, Park Tae-In, Lee Myung-Hoon
Abstract excerpt
PURPOSE: Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease entity due to diverse clinical outcomes to treatment. Most anticancer agents, regardless of their distinct mechanisms of action, ultimately kill cancer cells by inducing apoptosis. Accordingly, the present study analyzed the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.